NTRK2 and Alzheimer disease: AD treatment during postnatal days 4–21 produces long-term changes in bdnf and trkB mRNA expression in mice [17], which suggest that BDNF-TrkB signalling may play a role in the long-term behavioural consequences of AD treatment in early life.